Friday, the National Medicines Safety Agency (ANSM) had mentioned a situation “of strong supply tensions” which could last until March.
mo12345lemonde with AFP
The shortage of paracetamol in pharmacies will be settled “in the coming weeks” and that of the amoxicillin antibiotic will be “in the weeks, the coming months,” said the Minister of the Health, François Braun. “We have tensions on our drug stocks, it’s a reality,” said the minister, interviewed during the program “The Grand Jury RTL-Le Figaro-Lci”.
According to him, with regard to paracetamol: “In the coming weeks we will have solved this problem, with stocks that will have returned to a normal level.” He listed the actions undertaken to remedy this shortage: “The pharmacists have limited the number of boxes [sold per person] – since it is a product that can be given without a prescription – we have arrested industry manufacturers to increase production channels, which work seven days a week and twenty four hours a day. “
Regarding amoxicillin, the main antibiotic prescribed to children in France to fight against a series of bacterial infections, such as certain ear infections and pneumonies, Mr. Braun recognized that a date of return to normal was “difficult To say “, then said:” in the weeks, the coming months “.
🔴🗣 shortage of amoxicillin: the Minister of Health François Braun (@frcsbraun) provides for a return to normal “dan… https://t.co/nn4yqu6pr0
“Strong supply tensions”
“We have remobilized the entire sector, we prohibit the resale of amoxicillin” to “other countries”. “I authorized pharmacists to deconditioning,” he also said. The authorities also called on doctors and patients to use these antibiotics only if it is really necessary.
Friday, the National Medicines Safety Agency (ANSM) spoke of a “strong supply tensions” which could last until March. “The stake, which is major, is that it is not drugs that are produced in France,” said François Braun, stressing that the government’s “France 2030” investment plan was aimed at “repatriating all these Industries that produce these essential drugs in France, Europe, to ensure our sovereignty “.
According to health authorities, this shortage is explained by an increase in demand for several years marked by the COVVI-19 crisis and multiple health restrictions which had reduced the spread of certain diseases.